Skip to content | |||||
|
|||||
|
|||||||||||||||||
|
Under an agreement signed in FY04, Harvard University’s Beth Israel Deaconess Medical Center (BIDMC) is working toward the goal of refining the use of Goddard’s Hilbert-Huang Transform technology for a variety of medical advancements. The collaborative effort is expected to enhance monitoring of patients at risk for sudden cardiac failure and stroke as well as diagnosis and treatment of depression and other neurological disorders. The research was also designed to use HHT to analyze physiological signals in order to measure the vitality of various systems within the body. During FY06, BIDMC scientists worked directly with Dr. Huang to understand the HHT algorithms and to apply them to analyses of physiological signals, enabling better monitoring of cardiac and neurological diseases.
|
||||||||||||||||
|
|||||||||||||||||